COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 248.4 | 8 | 0133-0413 | 581.10 | 413.40 | 417 | 79.74 | 0.824 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 267.4 | 8 | 0134-0426 | 901.74 | 426.81 | 747 | 111.15 | 0.760 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 211.9 | 8 | 0135-0421 | 543.54 | 421.25 | 415 | 78.08 | 0.855 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.5 | 8 | 0136-0426 | 135.22 | 426.07 | 471 | 82.91 | 0.861 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 175.0 | 8 | 0137-0427 | 707.94 | 427.17 | 405 | 75.84 | 0.885 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 247.1 | 8 | 0138-0427 | 750.29 | 427.15 | 422 | 75.84 | 0.922 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 890.0 | 8 | 0139-0434 | 360.23 | 432.85 | 438 | 79.40 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 244.3 | 8 | 0140-0443 | 91.35 | 443.73 | 610 | 94.33 | 0.862 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 256.9 | 8 | 0141-0443 | 856.02 | 443.55 | 415 | 77.84 | 0.861 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 212.2 | 8 | 0142-0443 | 661.35 | 442.96 | 454 | 83.26 | 0.823 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 194.3 | 8 | 0143-0444 | 808.91 | 444.31 | 394 | 76.08 | 0.855 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 713.2 | 8 | 0144-0453 | 345.48 | 453.66 | 469 | 86.81 | 0.782 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 224.4 | 8 | 0145-0451 | 637.49 | 450.89 | 417 | 77.01 | 0.884 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 236.3 | 8 | 0146-0454 | 399.22 | 454.11 | 446 | 81.01 | 0.854 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 182.7 | 8 | 0147-0455 | 420.93 | 455.57 | 486 | 86.53 | 0.816 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.3 | 8 | 0148-0465 | 921.78 | 465.12 | 432 | 78.43 | 0.883 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 288.2 | 8 | 0149-0465 | 558.52 | 464.69 | 343 | 71.26 | 0.849 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.2 | 8 | 0150-0471 | 252.94 | 470.44 | 407 | 78.77 | 0.824 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 212.0 | 8 | 0151-0477 | 732.29 | 477.24 | 423 | 78.91 | 0.854 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 179.5 | 8 | 0152-0476 | 882.86 | 476.52 | 399 | 73.84 | 0.920 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 451.9 | 8 | 0153-0485 | 32.98 | 484.12 | 857 | 113.54 | 0.835 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 225.8 | 8 | 0154-0480 | 451.55 | 479.73 | 419 | 78.08 | 0.864 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 190.3 | 8 | 0155-0481 | 500.13 | 481.23 | 432 | 84.33 | 0.763 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 167.6 | 8 | 0156-0483 | 808.31 | 482.90 | 444 | 80.08 | 0.870 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 206.0 | 8 | 0157-0482 | 830.66 | 481.79 | 391 | 81.01 | 0.749 |